Journalartikel

COAGULATION ACTIVATION IN LIVER-DISEASES


AutorenlisteKEMKESMATTHES, B; BLEYL, H; MATTHES, KJ

Jahr der Veröffentlichung1991

Seiten253-261

ZeitschriftThrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis

Bandnummer64

Heftnummer2

ISSN0049-3848

DOI Linkhttps://doi.org/10.1016/0049-3848(91)90124-F

VerlagElsevier


Abstract
In liver disorders alterations of the coagulation system are mainly due to a reduced synthesis of coagulation proteins. In addition, an enhanced intravascular consumption of coagulation factors is discussed controversely in liver diseases. By measuring factor IX(i)AT-and TAT-complexes we tried to find out, whether coagulation activation in liver patients leads to activation of the complete coagulation cascade followed by DIC or whether in some diseases a futile partial coagulation activation develops. In all liver diseases examined, elevated factor IX(i)AT-complexes were demonstrated, while TAT-complexes were only elevated in chronic active hepatitis, metabolic decompensated liver cirrhosis and in patients suffering from end stage liver disease. We conclude that all liver diseases examined lead to an activation of the coagulation cascade. A complete activation followed by DIC only occurs in patients with very severe liver disorders.



Zitierstile

Harvard-ZitierstilKEMKESMATTHES, B., BLEYL, H. and MATTHES, K. (1991) COAGULATION ACTIVATION IN LIVER-DISEASES, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis, 64(2), pp. 253-261. https://doi.org/10.1016/0049-3848(91)90124-F

APA-ZitierstilKEMKESMATTHES, B., BLEYL, H., & MATTHES, K. (1991). COAGULATION ACTIVATION IN LIVER-DISEASES. Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis. 64(2), 253-261. https://doi.org/10.1016/0049-3848(91)90124-F



Schlagwörter


CIRRHOSISCOAGULATION ACTIVATIONDEGRADATION PRODUCTFACTOR-IXIAT-COMPLEXFIBRINOGENFIBRINOPEPTIDE-AINTRAVASCULAR COAGULATIONLIVER DISEASETAT-COMPLEX

Zuletzt aktualisiert 2025-02-04 um 06:08